Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
David West, Jr, CEO and Founder of Proscia, discusses a new realm of digital pathology and how it can improve health care for doctors and patients.
David West, Jr, CEO and Founder of Proscia, discusses a new realm of digital pathology and how it can improve health care for doctors and patients.
Joseph Vassalotti, MD, discusses the importance of urine testing in patients at risk for chronic kidney disease, such as diabetes and hypertension, and the importance of kidney-protective therapies that can...
Joseph Vassalotti, MD, discusses the importance of urine testing in patients at risk for chronic kidney disease, such as diabetes and hypertension, and the importance of kidney-protective therapies that can...
Etie Moghissi, MD, FACP, FACE, discusses a new web-based program designed by the American College of Endocrinology to help patients reduce complications and achieve glycemic control.
Etie Moghissi, MD, FACP, FACE, discusses a new web-based program designed by the American College of Endocrinology to help patients reduce complications and achieve glycemic control.
Michael Banks, MD, discusses the new genomic test created to determine a patient's tumor mutation burden, which could help identify patients that would benefit from...
Michael Banks, MD, discusses the new genomic test created to determine a patient's tumor mutation burden, which could help identify patients that would benefit from...
